An empirical Bayes model for gene expression and methylation profiles in antiestrogen resistant breast cancer
<p>Abstract</p> <p>Background</p> <p>The nuclear transcription factor estrogen receptor alpha (ER-alpha) is the target of several antiestrogen therapeutic agents for breast cancer. However, many ER-alpha positive patients do not respond to these treatments from the begi...
Main Authors: | Huang Tim, Nephew Kenneth P, Liu Yunlong, Li Lang, Jeong Jaesik, Shen Changyu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-11-01
|
Series: | BMC Medical Genomics |
Online Access: | http://www.biomedcentral.com/1755-8794/3/55 |
Similar Items
-
Poly-ADP-Ribosylation of Estrogen Receptor-Alpha by PARP1 Mediates Antiestrogen Resistance in Human Breast Cancer Cells
by: Nicholas Pulliam, et al.
Published: (2019-01-01) -
An empirical Bayes model using a competition score for metabolite identification in gas chromatography mass spectrometry
by: Kim Seongho, et al.
Published: (2011-10-01) -
The pitfall of the transient, inconsistent anticancer capacity of antiestrogens and the mechanism of apparent antiestrogen resistance
by: Suba Z
Published: (2015-08-01) -
Increased expression of the HDAC9 gene is associated with antiestrogen resistance of breast cancers
by: Aurélien Linares, et al.
Published: (2019-07-01) -
Autophagy and senescence facilitate the development of antiestrogen resistance in ER positive breast cancer
by: Michael K. McGrath, et al.
Published: (2024-03-01)